Diagnosis of growth hormone deficiency in adults

Hormone Research in Paediatrics

Volumn 46, Issue 4-5, 1996, Pages 174-182

  Korbonits, Márta ^a   Besser, Michael ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

GH tests; Growth hormone deficiency

Indexed keywords

ARGININE; CLONIDINE; GLUCAGON; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE; ANALYTIC METHOD; BLOOD LEVEL; BODY COMPOSITION; BONE DENSITY; CLINICAL CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS FUNCTION; INSULIN TOLERANCE TEST; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; OBESITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROVOCATION TEST; SEX DIFFERENCE; SLEEP; WELLBEING;

ADULT; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; KINETICS; MALE;

EID: 0029798019     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185019     Document Type: Article

References (62)

1. Cunco RC, Salmon F, McGauley GA, Sönksen PH: The growth hormone deficiency syndrome in adults, Clin Endocrinol (Oxl) 1992:37:387-397.
2. Salomon F, Cunco RC, Hesp R, Sönksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency, N Engl J Med 1989:321: 1797-1803.
3. Whitehead HM, Boreham C, Mclirath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR: Growth hormone treatment of adults with growth hormone deficiency: Results of 13 month placebo controlled cross-over study, Clin Endocrinol (Oxf) 1992;36:45-52.
4. Dcgerbald M, Elgindv L, Hall K, Sjöbcrg E, Thoren M: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism, Acta Endocrinol (C'openh) 1992:126: 387-393.
5. Orme SM, Sebastian JP, Oldroyd B, Stewart SPG, Stickland PJ, Smith MA, Bclchctz PE: Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy, Clin Endocrinol (Oxf) 1992:37: 453-459.
6. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalcl SM: Increased bone density after recombinant human growth hormone (G1I) therapy in adults with isolated GH deficiency, J Clin Endocrinol Metab 1993; 76:1344-1348.
7. Jörgenssen J, Thuesen L, Miiller J, Ovescn P, Skakkebaek NS, Christiansen JS: Three years of growth hormone treatment in growth hormone-deficient adults: Near normalization of body composition and physical performance, Eur J Endocrinol 1994;130:224-228.
8. de Boer H, Blok GJ, Van der Veen EA: Clinical aspects of growth hormone deficiency in adults, EndocrRev 1995:16:63-86.
9. Hoffman DM, O’Sullivan AJ, Baxter RC, Ho KKY: Diagnosis of growth-hormone deficiency in adults, Lancet 1994;343:1064-1069.
10. Thomer MO, Bengtsson B, Ho KKY, Alberts-son-Wikland K, Christiansen GS, Faglia G, Irie M, Isaksson O, Jörgenssen J, Ranke M, Roscn-feld R, Shalct S, Takano K, Van der Veen EA, Weissberg A: The diagnosis of growth hormone deficiency (GHD) in adults, J Clin Endocrinol Metab 1995:80:3097-3098.
11. Labram EK, Wilkin TJ: Growth hormone deficiency in adults and its response to growth hormone replacement, Q J Med 1995:88:391-399.
12. Iranmancsh A, Lizarraldc G, Veldhuis JD: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy man, J Clin Endocrinol Metab 1991:73:1081-1088.
13. Baum HA, Biller BMK, Katznelson L, Oppen-heim DS, Clemmons DR, Cannistarro KB, Schoenfcld DA, Best SA, Klibanski A: Assessment of growth hormone (GH) secretion in men with adult-onsct GH deficiency compared with that in normal men - A clinical research study, J Clin Endocrinol Metab 1996:81:84-92.
14. Martin-Hernandez T, Diaz Glavez M, Torres Cuadro A: Growth hormone secretion in normal prepubertal children: Importance of relations between endogenous secretion, pulsatility and body mass, Clin Endocrinol (Oxf) 1996:44: 327-334.
15. Reutens AT, Hoffman DM, Leung K, Ho KKY: Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency, J Clin Endocrinol Metab 1995:80:480-485.
16. Morcira-Andres MN, Canizo FJ, Hawkins F: Is there a place for urinary growth hormone measurement? Acta Endocrinol (Copenh) 1996; 128:197-201.
17. Hourd P, Edwards R: Current methods for the measurement of growth hormone in urine, Clin Endocrinol (Oxl) 1994:40:155-170.
18. Maghnie M, Valtorta A, Moretta M, Larizza D, Preti P, Palladini G, Calccnte S, Severi F: Diagnosing growth hormone deficiency: The value of short-term hypocaloric diet, J Clin Endocrinol Metab 1994:77:1372-1378.
19. Buckler JMH: Plasma growth hormone response to exercise as a diagnostic aid, Arch Dis Child 1973:48:565-567.
20. Roscnfeld RL, Cara JF: Somatic growth and maturation: in DeGroot LJ (ed): Endocrinology, ed 3, Philadelphia, Saunders, 1995, pp 2549-2589.
21. Rosenfeld RG, Albertsson-Wikland K, Cassor-la F, Frasier SD, Hasegawa Y, Hintz RL, La-franchi S, Lippc B, Loriaux L, Melmed S, Precce MA, Ranke M, Reiter EO, Rogol AD, Underwood LE.Werther GA: Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited, J Clin Endocrinol Metab 1995:80:1532-1540.
22. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zciscl HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-dcpcn-denl somatomedin-binding protein: Its use for the diagnosis of GH deficiency, J Clin Endocrinol Metab 1990:70:1292-1298.
23. Koppeschaar HPF, lenHom CD, Thijjsen JHH, Page MD, Dieguez C, Scanlon MF: Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion, Clin Endocrinol (Oxf) 1992;36:487-490.
24. Jones SL, Trainer PJ, Perry L, Wass JAH, Bes-scr GM, Grossman AB: An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year, Clin Endocrinol (Oxf) 1994:41:123-128.
25. Trainer PJ, Besser GM: The Bart’s Endocrine Protocols, London, Churchill Livingstone, 1995.
26. Muggeo M, Fcdelc D, Tiengo A, Molinari M, Crepaldi G: Human growth hormone and cortisol response to insulin stimulation in aging, J Gerontol 1975;30:546-551.
27. Sartorio A, Conti A, Monzani M: New markers of bone and collagen turnover in children and adults with growth hormone deficiency, Postgrad Med J 1993:69:846-850.
28. Amato G, Carella C, Fazio S, La Montagna G, Citladini A, Sabatini D, Marciano-Mone C, Saccä L, Bellastella A: Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses, J Clin Endocrinol Metab 1993:77:1671-1676.
29. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM: Reduced bone mineral density in patients with adult onset growth hormone deficiency, J Clin Endocrinol Metab 1994;78:669-674.
30. Shahi M, Beshyah SA, Hacked D, Sharp PS, Johnston DG: Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality, Br Heart J 1992:67:92-96.
31. Rosen T, Bosaeous I, Tölli J, Lindsted G, Bengtsson BA: Increased body fat mass and decreased extracellular fluid volume in adults withgrowth hormone deficiency, Clin Endocrinol (Oxf) 1993:38:63-71.
32. Mitchell ML, Byrne MY, Sanchez Y: Growth hormone deficiency, N Engl J Med 1970:382: 537-541.
33. Cordido F, Dieguez C, Casanueva FF: Effect of central cholinergic ncurolransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects, J Clin Endocrinol Metab 1990:70: 1361-1370.
34. Korbonits M, Trainer PJ, Fanciulli G, Oliva O, Pala A, Deltori A, Besser M, Delitala G, Grossman AB: I-Arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide, Eur J Endocrinol, in press.
35. Ghigo E, Bellone J, Arvat E, Mazza E, Valetto MR, Boffano GM, Cappa M, Loche S, Sanctis C, Miiller EE, Cammani F: Pyridostigmine potentiates L-Dopa- but not arginine and galanin-induced growth hormone secretion in children, Neuroendocrinol 1990:52:42-45.
36. Rahim A, Toogood AA, Shalet SM: The assessment of growth hormone status in normal young healthy adult males using four provocation agents, J Endocrinol 1996:128:(suppl): 288.
37. Kelijman M, Frohman LA: ß-Adrenergic modulation of growth hormone (GH) autofcedback on sleep-associated and pharmacologically induced GH secretion, J Clin Endocrinol Metab 1989;69:1187-1191.
38. Grossman AB, Savage MO, Wass JAH, Lytras N, Sueiras Diaz J, Coy DH, Besser GM: Growth hormone-releasing factor in growth hormone deficiency: Demonstration of a hypothalamic defect in growth hormone release, Uncet 1983;2: 137-138.
39. Grossman AB, Savage MO, Lytras N, Preece MA, Sueiras Diaz J, Coy DH, Rees LH, Besser GM: Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth hormone deficient children and young adults, Clin Endocrinol (Oxf) 1984:21: 321-330.
40. Cammani F: Diagnosis of growth hormone deficiency, J Endocrinol Invest 1994; 17:367-370.
41. Korbonits M, Grossman AB: Growth hormone-releasing peptide and its analogues: Novel stimuli to growth hormone release, Trends Endocrinol Metab 1995:6:43-49.
42. Hayashi S, Kaji H, Ohashi S, Abe H, Chihara K: Effect of intravenous administration of growth hormone-releasing peptide on plasma growth hormone in patients with short stature, Clin Paediatr Endocrinol 1993:2(suppl 2):69-74.
43. Pombo M, Barreiro J, Penalva A, Peino R, Dic-guez C, Casanucva FF: Absence of growth-hor-mone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-rclcasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary-stalk transection, J Clin Endocrinol Metab 1995:80:3180-3184.
44. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF: Blocked growth hormone-releasing peptide (GHRP)-6Finduced growth hormone secretion and absence of the synergic action of GHRP-6 plus growth hormone-releasing hormone in patients with hvpo-thalamopituitary disconnection - Evidence that GHRP-6 main action is exerted at the hypothalamic level, J Clin Endocrinol Metab 1995;80:942-947.
45. Ghigo E, Arvat E, Rizzi G, Goffi S, Grottoli S, Mucci M, Boghcn MF, Camanni F: Growth hormone-releasing activity of growth hormone-releasing pcptide-6 is maintained alter shortterm oral pretrcatment with the hexapcptide in normal aging, Eur J Endocrinol 1994:131:499-503.
46. Laron Z, Frenkel J, Dcghenghi R, Anin S, Klinger B, Silbergcld A: Intranasal administration of the GHRP hexarelin accelerates growth in short children, Clin Endocrinol (Oxf) 1995:43: 631-635.
47. Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR: Growth-hormone (GH) responses to GH-rcleasing peptide and to GH-releasing hormone in GH-dcficicnt children, J Clin Endocrinol Metab 1995:80:1681-1684.
48. Micic D, Popovic V, Kcndcrcski A, Macut D, Casanueva FF, Dieguez C: Growth-hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood, Clin Endocrinol (Oxf) 1995:42:191-194.
49. Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM: Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature, J Clin Endocrinol Metab 1995:80:2987-2992.
50. Korbonits M, Trainer PJ, Besser GM: The elTcct of an opiate antagonist on the hormonal changes induced by hexarelin, Clin Endocrinol (Oxf) 1995:43:365-371.
51. Bristow AF, Gaines-Das R, Jcffcoat SL, Schuls-ter D: The first international standard for somatotropin: Report of an international collaborative study, Growth Regul 1995:5:133-141.
52. Ranke MB: Growth hormone insufficiency: Clinical features, diagnosis, and therapy: in De-Groot U (cd): Endocrinology, ed 3, Philadelphia, Saunders, 1995, pp 330-340.
53. Tassoni P, Cacciari E, Cau M, Colli C, Tosi M, Zucchini S, Cicognani A, Pirazolli P, Salardi S, Balsamo A, Frejaville E, Cassio A, Zappula F: Variability of growth hormone response to pharmacological and sleep tests performed twice in short children, J Clin Endocrinol Mc-tab 1990:71:230-234.
54. Sonksen PH, Wcissberger AW, Verikou K: Diagnosing growth hormone deficiency in adults: in Adashi F.Y, Thorncr MO (cds): The Somatotrophic Axis of the Reproductive Process in Health and Disease, New York, Springer, 1995, pp 231-245.
55. Corpas E, Harman SM, Blackman MR: Human growth hormone and human aging, En-docrRev 1993:14:20-39.
56. Strobl JS, Thomas MJ: Human growth hormone, Pharmacol Rev 1994:46:1-34.
57. Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO: Neuroendocrine responses to a novel growth-hormone sccretagoguc, L-692.429, in healthy older subjects, J Clin Endocrinol Metab 1994:79:943-949.
58. Yamamoto H, Sohmiya M, Oka N, Kato Y: Effects of aging and sex on plasma insulin-like growth factor (IGF-I) levels in normal adults, Acta Endocrinol (Copenh) 1991:124:497-500.
59. Donahue LR, Hunter SJ, Sherblom AP, Rosen C: Age-related changes in serum insulin-like growth factor-binding proteins in women, J Clin Endocrinol Metab 1990;71:575-579.
60. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furnaletto R, Rogol AD, Kaiser DL, Thomer MO: Effects of sex and age on 24-hour profile of grow th hormone secretion in man: Importance of endogenous estradiol concentrations, J Clin Endocrinol Metab 1987;64:51-58.
61. Cordido F, Casanucva FF, Vidal JI, Dieguez C: Study of insulin-like growth factor I in human obesity, Horm Res 1991;36:187-191.
62. Cordido F, Penalva A, Dieguez C, Casanueva FF: Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence fora marked somatotroph secretory capability in obesity, J Clin Endocrinol Metab 1993:76:819-823.